Advanced Stem Cell Transplants for Blood Cancer Patients

For patients suffering from blood cancers, a stem cell transplant can be a life saving procedure. With allogeneic stem cell transplants, the stem cells are taken from a matched donor (typically a family member) and infused into an immune suppressed… [Learn More…]

Determining Time to First Treatment for Patients With Chronic Lymphocytic Leukemia (CLL)

The time to progression for CLL can vary greatly between patients with some patients never needing treatment and others with aggressive disease requiring early treatment. For newly diagnosed patients, the uncertainty of the current “wait-and-see… [Learn More…]

Cetuximab and Chemoradiation Therapy Significantly Improves Overall Survival of Patients with Unresectable Stage III NSCLC

Non-small cell lung cancers (NSCLC) commonly express the epidermal growth factor receptor (EGFR), which is associated with poor clinical outcome. Cetuximab is an inhibitor of EGFR and has radio-sensitization properties. In this study of patients… [Learn More…]

Keeping Abreast Of Breast Cancer

This article was written for and previously published in the Fall 2011 edition of the Women’s magazine Encompass. The article explores some exciting new scientific information on cancer treatment and prevention for women over 50. READ ARTICLE -… [Learn More…]

JX-594 Update: Improved Survival for Patients with Advanced Hepatocellular Carcinoma

In this phase II trial of patients with advanced, previously treated hepatocellular carcinoma (HCC),  52% of patients exhibited disease stabilization. The median overall survival was  13.8 mths with 25% of patients survived 32 mths (to date)…. [Learn More…]

Vandetanib for Locally Advanced or Metastatic Medullary Thyroid Cancer (MTC)

Medullary thyroid cancer (MTC) can usually be treated with surgery. However, treatment options for patients with unresectable, recurrent or metastatic MTC are limited. Mutations in the RET gene are common in sporadic MTC with the most common… [Learn More…]

Exemestane Offers New Option for Breast-Cancer Prevention

Exemestane is an aromatase inhibitor that substantially reduces the risk of invasive breast cancer in postmenopausal women at high risk of developing the disease. A 3yr follow up found that patients who took exemestane were 65% less likely to… [Learn More…]

Cabozantinib for Castration-Resistant Prostate Cancer

Cabozantinib is a multiple tyrosine kinase inhibitor that blocks the vascular endothelial growth factor receptor (VEGFR) and the receptor of hepatocyte growth factor (C-MET), resulting in significant benefits for patients with metastatic prostate… [Learn More…]

T Cell Therapy for EBV-Positive Nasopharyngeal Carcinoma

One of the causes of Nasopharyngeal Carcinoma (NPC) is an oncogenic protein made by the Epstein-Barr virus (EBV), referred to as the latent membrane protein 1 (LMP1). EBV-specific cytotoxic T cells (EBV-CTLs) therapy is a process where T-cells are… [Learn More…]

Thalidomide and Radiotherapy for Metastatic Angiosarcoma

Thalidomide is a sedative that was originally designed to cure morning sickness  but was recalled after it was found to cause severe birth defects. In this study, a 62 year old male with metastatic angiosarcoma was treated with a combination of… [Learn More…]